Manufacturer
Stemline Therapeutics
- Products listed
- 3
- Molecules
- 2
- Therapy areas
- 1
Stemline Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Stemline Therapeutics B.V., Stemline Therapeutics, Inc.
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Stemline Therapeutics products through licensed channels, with the documents your regulator needs.
Oncology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Elzonris 1000 mcg/1 mL injectionIntravenous Cold chain | Tagraxofusp | US FDA | Available on request |
| Orserdu 345 mg tabletOral | Elacestrant | US FDA | Available on request |
| Orserdu 86 mg tabletOral | Elacestrant | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Stemline Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.